Chemotherapy cycles antineoplastic combined chemotherapy protocols. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Cell Line, Tumor Tumor Cells, Cultured Bone Marrow Cell Line

Organisms1

Diseases71

Osteosarcoma Precursor Cell Lymphoblastic Leukemia-Lymphoma Breast Neoplasms Neutropenia Lung Neoplasms Neoplasms Hodgkin Disease Carcinoma, Non-Small-Cell Lung Neoplasm Recurrence, Local Ovarian Neoplasms Neoplasm Metastasis Adenocarcinoma Vomiting Nausea Lymphoma, Non-Hodgkin Colorectal Neoplasms Testicular Neoplasms Brain Neoplasms Bone Neoplasms Leukopenia Liver Neoplasms Neoplasms, Germ Cell and Embryonal Carcinoma, Small Cell Carcinoma, Squamous Cell Lymphoma Carcinoma Recurrence Peritoneal Neoplasms Lymphatic Metastasis Stomach Neoplasms Disease Progression Leukemia, Myeloid, Acute Germinoma Colonic Neoplasms Thrombocytopenia Head and Neck Neoplasms Sarcoma Pancreatic Neoplasms Neoplasm, Residual Multiple Myeloma Leukemia Leukemia, Myeloid Lymphoma, Large B-Cell, Diffuse Retroperitoneal Neoplasms Seminoma Leukemia P388 Stomatitis Mediastinal Neoplasms Glioma Hematologic Diseases Central Nervous System Neoplasms Neoplasms, Second Primary Drug-Related Side Effects and Adverse Reactions Esophageal Neoplasms Neoplasms, Experimental Nasopharyngeal Neoplasms Rectal Neoplasms Neoplasms, Glandular and Epithelial Prostatic Neoplasms Mesothelioma Dysgerminoma Urinary Bladder Neoplasms Soft Tissue Neoplasms Melanoma Leukemia L1210 Mucositis Medulloblastoma Neuroblastoma Fatigue Pleural Neoplasms Retinal Neoplasms

Chemicals and Drugs80

Antineoplastic Agents Doxorubicin Cyclophosphamide Cisplatin Vincristine Etoposide Paclitaxel Ifosfamide Granulocyte Colony-Stimulating Factor Taxoids Carboplatin Deoxycytidine Antiemetics Methotrexate Antibiotics, Antineoplastic Antineoplastic Agents, Phytogenic Antimetabolites, Antineoplastic Antineoplastic Agents, Alkylating Vinblastine Fluorouracil Epirubicin Bleomycin Organoplatinum Compounds Cytarabine Anthracyclines Recombinant Proteins Carmustine Camptothecin Daunorubicin Lomustine Mitomycin Dacarbazine Melphalan Prednisone Mitoxantrone Tumor Markers, Biological Antibodies, Monoclonal, Humanized Platinum Compounds Cell Cycle Proteins Thiotepa Antibodies, Monoclonal Tegafur 6-Mercaptopurine Floxuridine Bridged Compounds Vindesine Platinum P-Glycoprotein Dexamethasone Oxonic Acid Mitomycins Antibodies, Monoclonal, Murine-Derived Receptor, erbB-2 Prednisolone Angiogenesis Inhibitors Tumor Suppressor Protein p53 Mesna Receptors, Estrogen Gallium Nimustine Granisetron RNA, Messenger Topotecan Tamoxifen Enzyme Inhibitors Bryostatins Asparaginase Neoplasm Proteins Ellipticines Drug Combinations Thymidylate Synthase Prodrugs Phospholipid Ethers Antineoplastic Agents, Hormonal Nitrosourea Compounds Chlorambucil Ondansetron Proto-Oncogene Proteins c-bcl-2 Thioguanine Radiopharmaceuticals

Analytical, Diagnostic and Therapeutic Techniques and Equipment72

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Combined Modality Therapy Disease-Free Survival Treatment Outcome Prognosis Drug Administration Schedule Neoplasm Staging Retrospective Studies Survival Analysis Survival Rate Neoadjuvant Therapy Follow-Up Studies Prospective Studies Infusions, Intravenous Clinical Protocols Induction Chemotherapy Chemotherapy, Cancer, Regional Perfusion Salvage Therapy Clinical Trials as Topic Transplantation, Autologous Radiotherapy Radiotherapy, Adjuvant Drug Screening Assays, Antitumor Kaplan-Meier Estimate Infusions, Intra-Arterial Randomized Controlled Trials as Topic Hematopoietic Stem Cell Transplantation Drug Therapy Palliative Care Radiotherapy Dosage Drug Evaluation Xenograft Model Antitumor Assays Antineoplastic Protocols Feasibility Studies Immunohistochemistry Chemoradiotherapy Hyperthermia, Induced Multivariate Analysis Maintenance Chemotherapy Cranial Irradiation Clinical Trials, Phase III as Topic Actuarial Analysis Pilot Projects Administration, Oral Neoplasm Transplantation Bone Marrow Transplantation Predictive Value of Tests Proportional Hazards Models Risk Factors Tomography, X-Ray Computed Flow Cytometry Fatal Outcome Mastectomy Tumor Burden Consolidation Chemotherapy Treatment Failure Clinical Trials, Phase II as Topic Drug Evaluation, Preclinical Neoplasms, Experimental Drug Delivery Systems Hematopoietic Stem Cell Mobilization Research Design Random Allocation Reverse Transcriptase Polymerase Chain Reaction Positron-Emission Tomography Infusions, Parenteral Cohort Studies Models, Biological Inhibitory Concentration 50 Immunotherapy Blotting, Western

Phenomena and Processes20

Cell Cycle Drug Resistance, Neoplasm Time Factors Dose-Response Relationship, Drug Apoptosis Menstrual Cycle Cell Survival Drug Synergism Cell Proliferation Cell Division Gene Expression Regulation, Neoplastic Drug Resistance, Multiple Estrous Cycle DNA Damage Drug Resistance Citric Acid Cycle Mutation Signal Transduction Cell Cycle Checkpoints Inhibitory Concentration 50

Disciplines and Occupations4

Immunohistochemistry Medical Oncology Oncology Nursing Research Design

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Humanities1

Quality of Life

Information Science2

Survival Rate Fatal Outcome

Health Care29

Disease-Free Survival Treatment Outcome Retrospective Studies Survival Analysis Survival Rate Follow-Up Studies Prospective Studies Clinical Protocols Clinical Trials as Topic Kaplan-Meier Estimate Randomized Controlled Trials as Topic Palliative Care Antineoplastic Protocols Feasibility Studies Multivariate Analysis Clinical Trials, Phase III as Topic Actuarial Analysis Pilot Projects Predictive Value of Tests Proportional Hazards Models Risk Factors Fatal Outcome Oncology Nursing Treatment Failure Age Factors Clinical Trials, Phase II as Topic Random Allocation Cohort Studies Cancer Care Facilities

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care

Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents Doxorubicin Chemotherapy, Adjuvant Cyclophosphamide Cisplatin Combined Modality Therapy Disease-Free Survival Treatment Outcome Vincristine Prognosis Osteosarcoma Drug Administration Schedule Precursor Cell Lymphoblastic Leukemia-Lymphoma Etoposide Cell Cycle Breast Neoplasms Neoplasm Staging Paclitaxel Retrospective Studies Ifosfamide Neutropenia Lung Neoplasms Survival Analysis Neoplasms Granulocyte Colony-Stimulating Factor Taxoids Carboplatin Survival Rate Neoadjuvant Therapy Deoxycytidine Antiemetics Methotrexate Hodgkin Disease Carcinoma, Non-Small-Cell Lung Antibiotics, Antineoplastic Antineoplastic Agents, Phytogenic Follow-Up Studies Antimetabolites, Antineoplastic Prospective Studies Antineoplastic Agents, Alkylating Infusions, Intravenous Vinblastine Drug Resistance, Neoplasm Clinical Protocols Fluorouracil Epirubicin Bleomycin Induction Chemotherapy Time Factors Neoplasm Recurrence, Local Organoplatinum Compounds Cytarabine Cell Line, Tumor Anthracyclines Recombinant Proteins Ovarian Neoplasms Dose-Response Relationship, Drug Neoplasm Metastasis Adenocarcinoma Vomiting Chemotherapy, Cancer, Regional Perfusion Nausea Salvage Therapy Apoptosis Lymphoma, Non-Hodgkin Carmustine Clinical Trials as Topic Colorectal Neoplasms Camptothecin Testicular Neoplasms Menstrual Cycle Transplantation, Autologous Radiotherapy Daunorubicin Lomustine Radiotherapy, Adjuvant Brain Neoplasms Drug Screening Assays, Antitumor Mitomycin Dacarbazine Bone Neoplasms Melphalan Leukopenia Prednisone Mitoxantrone Liver Neoplasms Neoplasms, Germ Cell and Embryonal Tumor Cells, Cultured Kaplan-Meier Estimate Carcinoma, Small Cell Tumor Markers, Biological Antibodies, Monoclonal, Humanized Platinum Compounds Infusions, Intra-Arterial Cell Survival Drug Synergism Cell Cycle Proteins Carcinoma, Squamous Cell Lymphoma

No FAQ available that match "chemotherapy cycles antineoplastic combined chemotherapy protocols"